Company News • Endpoint Arena

News Updates

Tue, May 12, 2026

1 updates

8:00 AM

OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies

opko.com

Thu, Apr 30, 2026

2 updates

8:30 AM

OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China

opko.com

8:00 AM

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

opko.com

Tue, Apr 28, 2026

1 updates

4:05 PM

OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results

Trial Start • Phase 1opko.com

Wed, Apr 22, 2026

1 updates

8:00 AM

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

Trial Start • Phase 1opko.com

Tue, Apr 21, 2026

1 updates

4:05 PM

OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026

opko.com

Wed, Apr 8, 2026

1 updates

8:00 AM

OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19

Trial Start • Phase 1opko.com